195 related articles for article (PubMed ID: 26948078)
1. Chronic mucocutaneous candidiasis associated with an SH2 domain gain-of-function mutation that enhances STAT1 phosphorylation.
Sobh A; Chou J; Schneider L; Geha RS; Massaad MJ
J Allergy Clin Immunol; 2016 Jul; 138(1):297-299. PubMed ID: 26948078
[No Abstract] [Full Text] [Related]
2. Two novel gain-of-function mutations of STAT1 responsible for chronic mucocutaneous candidiasis disease: impaired production of IL-17A and IL-22, and the presence of anti-IL-17F autoantibody.
Yamazaki Y; Yamada M; Kawai T; Morio T; Onodera M; Ueki M; Watanabe N; Takada H; Takezaki S; Chida N; Kobayashi I; Ariga T
J Immunol; 2014 Nov; 193(10):4880-7. PubMed ID: 25288569
[TBL] [Abstract][Full Text] [Related]
3. Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.
Tabellini G; Vairo D; Scomodon O; Tamassia N; Ferraro RM; Patrizi O; Gasperini S; Soresina A; Giardino G; Pignata C; Lougaris V; Plebani A; Dotta L; Cassatella MA; Parolini S; Badolato R
J Allergy Clin Immunol; 2017 Aug; 140(2):553-564.e4. PubMed ID: 28069426
[TBL] [Abstract][Full Text] [Related]
4. A novel gain-of-function STAT1 mutation resulting in basal phosphorylation of STAT1 and increased distal IFN-γ-mediated responses in chronic mucocutaneous candidiasis.
Martinez-Martinez L; Martinez-Saavedra MT; Fuentes-Prior P; Barnadas M; Rubiales MV; Noda J; Badell I; Rodríguez-Gallego C; de la Calle-Martin O
Mol Immunol; 2015 Dec; 68(2 Pt C):597-605. PubMed ID: 26514428
[TBL] [Abstract][Full Text] [Related]
5. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.
Liu L; Okada S; Kong XF; Kreins AY; Cypowyj S; Abhyankar A; Toubiana J; Itan Y; Audry M; Nitschke P; Masson C; Toth B; Flatot J; Migaud M; Chrabieh M; Kochetkov T; Bolze A; Borghesi A; Toulon A; Hiller J; Eyerich S; Eyerich K; Gulácsy V; Chernyshova L; Chernyshov V; Bondarenko A; Grimaldo RM; Blancas-Galicia L; Beas IM; Roesler J; Magdorf K; Engelhard D; Thumerelle C; Burgel PR; Hoernes M; Drexel B; Seger R; Kusuma T; Jansson AF; Sawalle-Belohradsky J; Belohradsky B; Jouanguy E; Bustamante J; Bué M; Karin N; Wildbaum G; Bodemer C; Lortholary O; Fischer A; Blanche S; Al-Muhsen S; Reichenbach J; Kobayashi M; Rosales FE; Lozano CT; Kilic SS; Oleastro M; Etzioni A; Traidl-Hoffmann C; Renner ED; Abel L; Picard C; Maródi L; Boisson-Dupuis S; Puel A; Casanova JL
J Exp Med; 2011 Aug; 208(8):1635-48. PubMed ID: 21727188
[TBL] [Abstract][Full Text] [Related]
6. Autosomal dominant gain of function STAT1 mutation and severe bronchiectasis.
Breuer O; Daum H; Cohen-Cymberknoh M; Unger S; Shoseyov D; Stepensky P; Keller B; Warnatz K; Kerem E
Respir Med; 2017 May; 126():39-45. PubMed ID: 28427548
[TBL] [Abstract][Full Text] [Related]
7. Recurrent inflammatory aortic aneurysms in chronic mucocutaneous candidiasis with a gain-of-function STAT1 mutation.
Tanimura M; Dohi K; Hirayama M; Sato Y; Sugiura E; Nakajima H; Kanemitsu S; Toyoda H; Yamada N; Masuya M; Imanaka-Yoshida K; Shimpo H; Azuma E; Ito M
Int J Cardiol; 2015 Oct; 196():88-90. PubMed ID: 26080282
[No Abstract] [Full Text] [Related]
8. Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC).
Zheng J; van de Veerdonk FL; Crossland KL; Smeekens SP; Chan CM; Al Shehri T; Abinun M; Gennery AR; Mann J; Lendrem DW; Netea MG; Rowan AD; Lilic D
Eur J Immunol; 2015 Oct; 45(10):2834-46. PubMed ID: 26255980
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of two STAT1 gain-of-function mutations in two Iranian families with autosomal dominant chronic mucocutaneous candidiasis.
Ostadi V; Sherkat R; Migaud M; Modaressadeghi SM; Casanova JL; Puel A; Nekooie-Marnany N; Ganjalikhani-Hakemi M
Med Mycol; 2021 Feb; 59(2):180-188. PubMed ID: 32526033
[TBL] [Abstract][Full Text] [Related]
10. Double Trouble? CMC with a Mutation in both AIRE and STAT1.
Al Dhanhani H; Al Shehri T; Lilic D; Buddles M; Kisand K; Maccari ME; Leahy TR
J Clin Immunol; 2018 Aug; 38(6):635-637. PubMed ID: 30054782
[No Abstract] [Full Text] [Related]
11. Chronic mucocutaneous candidiasis caused by a gain-of-function mutation in the STAT1 DNA-binding domain.
Takezaki S; Yamada M; Kato M; Park MJ; Maruyama K; Yamazaki Y; Chida N; Ohara O; Kobayashi I; Ariga T
J Immunol; 2012 Aug; 189(3):1521-6. PubMed ID: 22730530
[TBL] [Abstract][Full Text] [Related]
12. Clinical heterogeneity of dominant chronic mucocutaneous candidiasis disease: presenting as treatment-resistant candidiasis and chronic lung disease.
Dotta L; Scomodon O; Padoan R; Timpano S; Plebani A; Soresina A; Lougaris V; Concolino D; Nicoletti A; Giardino G; Licari A; Marseglia G; Pignata C; Tamassia N; Facchetti F; Vairo D; Badolato R
Clin Immunol; 2016 Mar; 164():1-9. PubMed ID: 26732859
[TBL] [Abstract][Full Text] [Related]
13. Autosomal-dominant chronic mucocutaneous candidiasis with STAT1-mutation can be complicated with chronic active hepatitis and hypothyroidism.
Hori T; Ohnishi H; Teramoto T; Tsubouchi K; Naiki T; Hirose Y; Ohara O; Seishima M; Kaneko H; Fukao T; Kondo N
J Clin Immunol; 2012 Dec; 32(6):1213-20. PubMed ID: 22847544
[TBL] [Abstract][Full Text] [Related]
14. A gain-of-function mutation of STAT1: A novel genetic factor contributing to chronic mucocutaneous candidiasis.
Eslami N; Tavakol M; Mesdaghi M; Gharegozlou M; Casanova JL; Puel A; Okada S; Arshi S; Bemanian MH; Fallahpour M; Molatefi R; Seif F; Zoghi S; Rezaei N; Nabavi M
Acta Microbiol Immunol Hung; 2017 Jun; 64(2):191-201. PubMed ID: 28597685
[TBL] [Abstract][Full Text] [Related]
15. Chronic mucocutaneous candidiasis due to gain-of-function mutation in STAT1.
Carey B; Lambourne J; Porter S; Hodgson T
Oral Dis; 2019 Apr; 25(3):684-692. PubMed ID: 29702748
[TBL] [Abstract][Full Text] [Related]
16. Treatment options for chronic mucocutaneous candidiasis.
van de Veerdonk FL; Netea MG
J Infect; 2016 Jul; 72 Suppl():S56-60. PubMed ID: 27161991
[TBL] [Abstract][Full Text] [Related]
17. Recurrent, Severe Aphthous Stomatitis and Mucosal Ulcers as Primary Manifestations of a Novel
Erdős M; Jakobicz E; Soltész B; Tóth B; Bata-Csörgő Z; Maródi L
Front Immunol; 2020; 11():967. PubMed ID: 32547544
[TBL] [Abstract][Full Text] [Related]
18. Utility of Ruxolitinib in a Child with Chronic Mucocutaneous Candidiasis Caused by a Novel STAT1 Gain-of-Function Mutation.
Bloomfield M; Kanderová V; Paračková Z; Vrabcová P; Svatoň M; Froňková E; Fejtková M; Zachová R; Rataj M; Zentsová I; Milota T; Klocperk A; Kalina T; Šedivá A
J Clin Immunol; 2018 Jul; 38(5):589-601. PubMed ID: 29934865
[TBL] [Abstract][Full Text] [Related]
19. Case Report: Disseminated
Chen K; Tan J; Qian S; Wu S; Chen Q
Front Immunol; 2021; 12():682350. PubMed ID: 34421897
[TBL] [Abstract][Full Text] [Related]
20. New and recurrent gain-of-function STAT1 mutations in patients with chronic mucocutaneous candidiasis from Eastern and Central Europe.
Soltész B; Tóth B; Shabashova N; Bondarenko A; Okada S; Cypowyj S; Abhyankar A; Csorba G; Taskó S; Sarkadi AK; Méhes L; Rozsíval P; Neumann D; Chernyshova L; Tulassay Z; Puel A; Casanova JL; Sediva A; Litzman J; Maródi L
J Med Genet; 2013 Sep; 50(9):567-78. PubMed ID: 23709754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]